A novel presenilin 1 mutation (Leu166Arg) associated with early-onset Alzheimer disease

Archives of Neurology

Volumn 57, Issue 4, 2000, Pages 485-488

  Ezquerra, Mario ^a   Carnero, Cristobal ^c   Blesa, Rafael ^b   Oliva, Rafael ^a,b  

^a UNIVERSITY OF BARCELONA   (Spain)

^b HOSPITAL CLÍNIC   (Spain)

^c HOSPITAL UNIVERSITARIO VIRGEN DE LAS NIEVES   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; HETERODUPLEX; LEUCINE; PRESENILIN 1;

ALZHEIMER DISEASE; ARTICLE; EXON; FAMILY STUDY; GENETIC ANALYSIS; HUMAN; MISSENSE MUTATION; PATHOGENESIS; PRIORITY JOURNAL; SINGLE STRAND CONFORMATION POLYMORPHISM;

EID: 0034041861     PISSN: 00039942     EISSN: None     Source Type: Journal    
DOI: 10.1001/archneur.57.4.485     Document Type: Article

References (29)

1. Sherrington R, Rogaev E, Liang Y, et al. Cloning a gene bearing missense mutation in early-onset familial Alzheimer's disease. Nature. 1995;375:754-760.
2. Levy-Lahad E, Wasco W, Poorkaj P, et al. Candidate gene for the chromosome 1 familial Alzheimer's disease locus. Science. 1995;269:973-977.
3. Goate A, Chartier-Harlin MC, Mullan M, et al. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature. 1991;349:704-709.
4. Saunders A, Strittmatter W, Schemechel D, et al. Association of apolipoprotein E allele ε4 with late-onset familial and sporadic Alzheimer's disease. Neurology. 1993;43:1467-1472.
5. Corder EH, Saunders AM, Strittmatter WJ, et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late-onset families. Science. 1993;261:921-923.
6. Adroer R, Santacruz P, Blesa R, Lopez-Pousa S, Ascaso C, Oliva R. Apolipoprotein E4 allele frequency in Spanish Alzheimer and control cases. Neurosci Lett. 1995;189:182-186.
7. Blesa R, Adroer R, Santacruz P, Ascaso C, Tolosa E, Oliva R. High apolipoprotein E allele frequency in age-related memory decline. Ann Neurol. 1996;39:548-552.
8. Kamboh MI, Sanghera DK, Ferrell RE, DeKosky ST. APOE4 associated Alzheimer's disease risk is modified by α-antichymotrypsin polymorphism. Nat Genet. 1995;10:486-488.
9. Ezquerra M, Blesa R, Tolosa E, Ballesta F, Oliva R. α-Antichymotrypsin and risk for Alzheimer's disease in the Spanish population. Neurosci Lett. 1998;240:107-109.
10. Okuizumi K, Onodera O, Namba Y, et al. Genetic association of the very low density lipoprotein (VLDL) receptor gene with sporadic Alzheimer's disease. Nat Genet. 1995;11:207-209.
11. Lehmann DJ, Johnston C, Smith AD. Synergy between the genes for butyrylcholinesterase K variant and apolipoprotein E4 in late-onset, confirmed Alzheimer's disease. Hum Mol Genet. 1997;6:1933-1936.
12. Blaker D, Wilcox MA, Laird NM, et al. Alpha-2 macroglobulin is genetically associated with Alzheimer disease. Nat Genet. 1998;19:357-360.
13. Kwan-Fu RS, Abraham AM, Vahram H, et al. Modulation of the genetic risk of Alzheimer's disease in a very elderly population. Ann Neurol. 1999;45:48-53.
14. Yasuda M, Maeda K, Hashimoto M, et al. A pedigree with a novel presenilin 1 mutation at a residue that is not conserved in presenilin 2. Arch Neurol. 1999; 56:65-69.
15. Hutton M, Busfield F, Wraag M, et al. Complete analysis of the presenilin 1 gene in early-onset Alzheimer's disease. Neuroreport. 1996;7:801-805.
16. Cruts M, Van Duijn CM, Backhoven H, et al. Estimation of the genetic contribution of presenilin-1 and -2 mutations in a population-based study of presenile Alzheimer's disease. Hum Mol Genet. 1998;7:43-51.
17. Wraag M, Hutton M, Talbot C, et al. Genetic association between intronic polymorphism in presenilin-1 gene and late-onset Alzheimer's disease. Lancet. 1996; 347:509-512.
18. Ezquerra M, Blesa R, Tolosa E, et al. The genotype 2/2 of the presenilin-1 is decreased in Spanish early-onset Alzheimer's disease. Neurosci Lett. 1997;227: 201-204.
19. Peña-Casanova J, Aguilar M, Bertrán-Serra I, et al. Normalización de instrumentas cognitivos y funcionales para la evaluación de la demencia (NORMACODEM), I: objetivos, contenidos y población. Neurologia. 1997;12:61-68.
20. Oliva R, Tolosa E, Ezquerra M, et al. Significant changes in the τ A0 and A3 alleles in progressive supranuclear palsy and improved genotyping by silver detection. Arch Neurol. 1998;55:1122-1124.
21. Wenham PR, Price WH, Blundell G. Apolipoprotein E genotyping by one-stage PCR. Lancet. 1991;337:1158-1159.
22. Ezquerra M, Carnero C, Blesa R, Gelpí JL, Ballesta F, Oliva R. A presenilin 1 mutation (Ser169Pro) associated with early-onset AD and myoclonic seizures. Neurology. 1999;52:566-570.
23. Ramírez MG, Rogaeva EA, Leal CA, et al. A novel Leu171Pro mutation in presenilin-1 gene in a Mexican family with early-onset Alzheimer disease. Ann Genet. 1998;41:149-153.
24. Kamino K, Sato S, Sakaji Y, et al. Mutational analysis of presenilin-1 gene in early-onset Alzheimer's disease [abstract]. Am J Hum Genet. 1996;59:2320.
25. Campion D, Flaman JL, Brice A, et al. Mutations of the presenilin 1 gene in families with early-onset Alzheimer's disease. Hum Mol Genet. 1995;4:2373-2377.
26. Kwok JB, Taddei K, Hallup M, et al. Two novel (M233T and R278T) presenilin-1 mutations in early-onset Alzheimer's disease pedigrees and preliminary evidence for association of presenilin-1 mutations with a novel phenotype. Neuroreport. 1997;14:1537-1542.
27. Crook R, Verkkoniemi A, Perez-Tur J, et al. A variant of Alzheimer's disease with spastic paraparesis and unusual plaques due to deletion of exon 9 of presenilin 1. Nat Med. 1998;4:452-455.
28. Perez-Tur J, Froelich S, Prihar G, et al. A mutation in Alzheimer's disease destroying a splice acceptor site in the presenilin 1 gene. Neuroreport. 1996;7: 297-301.
29. Tysoe C, Whittaker J, Xuereb J, et al. A presenilin-1 truncating mutation is present in two cases with autopsy-confirmed early-onset Alzheimer disease. Am J Hum Genet. 1998;62:70-76.